Medical Marijuana, Inc. announced that it has received the first-ever authorization in Bulgaria to sell hemp-derived cannabidiol (CBD) products.
“As the EU continues to navigate its stance on CBD, we are proud to continue paving the way for the acceptance of CBD in Bulgaria just as we have in many other countries around the world,” said Kannaway CEO Blake Schroeder. “With this authorization, we hope that we can establish our company as pioneers in Bulgaria’s CBD industry and leaders in CBD education throughout Europe.”
The authorization certifies that Kannaway’s imported goods are normally and freely sold in the certifying country’s open markets and are approved for export.
“As a company of firsts, we look forward to trailblazing the international CBD market as advocates of this supplement’s potential benefits,” said Kannaway Vice President of International Alex Grapov. “We have met with all of the appropriate regulatory bodies to ensure that our operations are within the bounds of the law creating a stable opportunity for our customers and Brand Ambassadors.”
Kannaway is a direct selling company specializing in the sales and marketing of hemp-based botanical products. CBD, a non-psychoactive cannabis compound found abundant in hemp, has been researched extensively for its antioxidant and anti-inflammatory properties.
